PONV remains a significant clinical challenge despite preventive antiemetic therapy. This phase III study explores whether it can safely and effectively rescue patients who develop PONV despite prophylactic antiemetic therapy.
A 24-year-old woman with KCNJ11-associated permanent neonatal diabetes mellitus presented with severe hyperglycemia and poor glycemic control despite insulin and sulfonylurea therapy. Click here to read the treatment approach that was taken.